Form 4: BioLife Solutions CFO Sells Shares for Tax Obligations

BioLife Solutions' CFO, Troy Wichterman, sold 1,032 shares of common stock at $26.83 per share to cover tax withholding obligations from restricted stock vesting.

Summary

• Troy Wichterman, Chief Financial Officer of BIOLIFE SOLUTIONS INC (BLFS), reported a sale of common stock.
• The transaction involved the disposition of 1,032 shares of common stock on September 11, 2025.
• The shares were sold at a price of $26.83 per share.
• The total value of the shares sold was $27,680.56.
• Following this transaction, Mr. Wichterman beneficially owns 184,186 shares of common stock directly.
• The sale was executed pursuant to a Rule 10b5-1(c) trading plan, which was adopted on March 8, 2024.
• The purpose of the sale was to satisfy tax withholding obligations related to the vesting of restricted stock.

Sentiment

Score: 5

Explanation: The filing reports a routine, pre-planned insider stock sale by the CFO to cover tax obligations from restricted stock vesting. This is a neutral event and does not indicate a change in company fundamentals or management's outlook.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This insider transaction is a routine event, common across all industries, where executives sell shares to cover tax liabilities arising from equity compensation vesting. It does not reflect specific industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: Minimal impact as this is a routine, pre-planned transaction for tax purposes and does not signal a change in management's confidence or company fundamentals.

Key Dates

Recommendation

The filing details a routine, pre-planned sale of shares by the CFO to cover tax obligations from restricted stock vesting. This is a common occurrence and does not indicate a change in the company's fundamentals or management's long-term outlook, thus warranting no change in investment recommendation.

Keywords

BioLife Solutions, BLFS, Troy Wichterman, CFO, Form 4, Insider Trading, Stock Sale, Rule 10b5-1, Tax Withholding, Restricted Stock